Natali Vega‐Magaña

Author

Natali Vega‐Magaña

Also Known As

A.N. Vega-Magana, Alejandra N Vega-Magaña, Alejandra N. Vega-Magaña, Alejandra Natali Vega-Magaña, Alejandra Natali Vega‐Magaña, N. Vega-Magaña, N. Vega‐Magaña, Natali Vega Magaña, Natali Vega-Magaña, Natali Vega‐Magaña

Publications

560

Citations

H-Index

Concepts

All Affiliations

Universidad de Guadalajara Hospital Civil de Guadalajara Universidad Autónoma de Nayarit

About

Natali Vega‐Magaña is an author at Universidad de Guadalajara specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	179
2	Cell Biology	3	3	52
3	Health Sciences	2	2	104
4	Gastroenterology	2	2	104
5	Epidemiology	1	1	23

Natali Vega‐Magaña

Publications

480

Citations

H-Index

Page 1

	Year	Citations
Escherichia/Shigella, SCFAs, and Metabolic Pathways—The Triad That Orchestrates Intestinal Dysbiosis in Patients with Decompensated Alcoholic Cirrhosis from Western Mexico Tonatiuh Abimael Baltazar-Díaz, Luz Alicia González-Hernández, J.M. Aldana-Ledesma, Microorganisms DysbiosisHost-microbe InteractionsGastroenterologyPathologyGut Microbiota	2022	84
RT-qPCR Assays for Rapid Detection of the N501Y, 69-70del, K417N, and E484K SARS-CoV-2 Mutations: A Screening Strategy to Identify Variants With Clinical Impact Natali Vega‐Magaña, R. Sánchez Sánchez, Jorge Hernández‐Bello, Frontiers in Cellular and Infection Microbiology	2021	75
Vitamin D Levels in COVID-19 Outpatients from Western Mexico: Clinical Correlation and Effect of Its Supplementation Gabriela Athziri Sánchez‐Zuno, Guillermo González-Estévez, Mónica Guadalupe Matuz-Flores, Journal of Clinical Medicine	2021	51
Alterations in bacterial communities, SCFA and biomarkers in an elderly HIV-positive and HIV-negative population in western Mexico Luz Alicia González-Hernández, Mariana del Rocío Ruiz-Briseño, Karina Sánchez-Reyes, BMC Infectious Diseases	2019	47
In Vivo Healthy Benefits of Galacto-Oligosaccharides from Lupinus albus (LA-GOS) in Butyrate Production through Intestinal Microbiota Lucila A. Godínez-Méndez, Carmen Magdalena Gurrola‐Díaz, J. Nuño, Biomolecules	2021	32
Butyrate administration strengthens the intestinal epithelium and improves intestinal dysbiosis in a cholestasis fibrosis model Marcela Peña‐Rodríguez, Natali Vega‐Magaña, Leonel García‐Benavides, Journal of Applied Microbiology	2021	25
Performance evaluation of a lateral flow assay for nasopharyngeal antigen detection for SARS‐CoV‐2 diagnosis Marcela Peña‐Rodríguez, Oliver Viera‐Segura, Mariel García‐Chagollán, Journal of Clinical Laboratory Analysis	2021	24
Phylogenomics and population genomics of SARS-CoV-2 in Mexico during the pre-vaccination stage reveals variants of interest B.1.1.28.4 and B.1.1.222 or B.1.1.519 and the nucleocapsid mutation S194L associated with symptoms Francisco Barona‐Gómez, Luis Delaye, Erik Díaz-Valenzuela, Microbial Genomics VaccinationViral EvolutionVirus EpidemiologyVaccination StageGenetics	2021	23
Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico Marcela Peña‐Rodríguez, Jorge Hernández‐Bello, Natali Vega‐Magaña, Frontiers in Public Health	2023	23
Loss of CD28 within CD4+ T cell subsets from cervical cancer patients is accompanied by the acquisition of intracellular perforin, and is further enhanced by NKG2D expression Marta Escarra‐Senmarti, Miriam Ruth Bueno‐Topete, Luis Felipe Jave‐Suárez, Immunology Letters Cancer ImmunosurveillanceCervical CancerNkg2d ExpressionIntracellular PerforinImmunology	2017	21

Page 1